437 related articles for article (PubMed ID: 20532540)
21. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
22. Acute exposure to prion infection induces transient oxidative stress progressing to be cumulatively deleterious with chronic propagation in vitro.
Haigh CL; McGlade AR; Lewis V; Masters CL; Lawson VA; Collins SJ
Free Radic Biol Med; 2011 Aug; 51(3):594-608. PubMed ID: 21466851
[TBL] [Abstract][Full Text] [Related]
23. Is the prion structure solved?
Liberski PP; Bratosiewicz-Zapart J
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):121-40. PubMed ID: 9597078
[TBL] [Abstract][Full Text] [Related]
24. Membrane toxicity of abnormal prion protein in adrenal chromaffin cells of scrapie infected sheep.
McGovern G; Jeffrey M
PLoS One; 2013; 8(3):e58620. PubMed ID: 23469286
[TBL] [Abstract][Full Text] [Related]
25. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
[TBL] [Abstract][Full Text] [Related]
26. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
[TBL] [Abstract][Full Text] [Related]
27. Effects of agent strain and host genotype on PrP accumulation in the brain of sheep naturally and experimentally affected with scrapie.
González L; Martin S; Begara-McGorum I; Hunter N; Houston F; Simmons M; Jeffrey M
J Comp Pathol; 2002 Jan; 126(1):17-29. PubMed ID: 11814318
[TBL] [Abstract][Full Text] [Related]
28. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
29. Detection of PrP in extraneural tissues.
Brown KL; Ritchie DL; McBride PA; Bruce ME
Microsc Res Tech; 2000 Jul; 50(1):40-5. PubMed ID: 10871547
[TBL] [Abstract][Full Text] [Related]
30. Scrg1 is induced in TSE and brain injuries, and associated with autophagy.
Dron M; Bailly Y; Beringue V; Haeberlé AM; Griffond B; Risold PY; Tovey MG; Laude H; Dandoy-Dron F
Eur J Neurosci; 2005 Jul; 22(1):133-46. PubMed ID: 16029203
[TBL] [Abstract][Full Text] [Related]
31. Galectin-3 expression is correlated with abnormal prion protein accumulation in murine scrapie.
Jin JK; Na YJ; Song JH; Joo HG; Kim S; Kim JI; Choi EK; Carp RI; Kim YS; Shin T
Neurosci Lett; 2007 Jun; 420(2):138-43. PubMed ID: 17531384
[TBL] [Abstract][Full Text] [Related]
32. [Molecular bases of prion diseases].
Rać M; Rać M
Ann Acad Med Stetin; 2006; 52(3):5-13. PubMed ID: 17385343
[TBL] [Abstract][Full Text] [Related]
33. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.
Lewis V; Hill AF; Haigh CL; Klug GM; Masters CL; Lawson VA; Collins SJ
J Neuropathol Exp Neurol; 2009 Oct; 68(10):1125-35. PubMed ID: 19918124
[TBL] [Abstract][Full Text] [Related]
34. Transgenic mouse models of prion diseases.
Telling GC
Methods Mol Biol; 2008; 459():249-63. PubMed ID: 18576160
[TBL] [Abstract][Full Text] [Related]
35. Lysosomes as key organelles in the pathogenesis of prion encephalopathies.
Laszlo L; Lowe J; Self T; Kenward N; Landon M; McBride T; Farquhar C; McConnell I; Brown J; Hope J
J Pathol; 1992 Apr; 166(4):333-41. PubMed ID: 1355530
[TBL] [Abstract][Full Text] [Related]
36. Retinal cell types are differentially affected in sheep with scrapie.
Smith JD; Greenlee JJ; Hamir AN; West Greenlee MH
J Comp Pathol; 2008 Jan; 138(1):12-22. PubMed ID: 18061608
[TBL] [Abstract][Full Text] [Related]
37. Reconstructing prions: fibril assembly from simple yeast to complex mammals.
Sigurdson C; Polymenidou M; Aguzzi A
Neurodegener Dis; 2005; 2(1):1-5. PubMed ID: 16908997
[TBL] [Abstract][Full Text] [Related]
38. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
Shim SY; Karri S; Law S; Schatzl HM; Gilch S
Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future.
Parchi P; Strammiello R; Giese A; Kretzschmar H
Acta Neuropathol; 2011 Jan; 121(1):91-112. PubMed ID: 21107851
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of prion disease progression: a chemical reaction network approach.
Méndez JM; Femat R
IET Syst Biol; 2011 Nov; 5(6):347-52. PubMed ID: 22129030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]